Vargas GS, Ramos VJR, Martín PY

Language: Spanish
References: 10
Page: 158-164
PDF size: 501.62 Kb.

ABSTRACT

Introduction: a pseudolymphoma is a benign, reversible, inflammatory, reactive and polyclonal lymphocytic proliferation that spontaneously regresses or heals after the elimination of the causal factor.
Patient information: the case of an 80-year-old female patient with disseminated, erythematous, pruritic skin lesions in the form of plaques and wheals associated with periorbital edema and pruritus is presented. The patient also presented target lesions simulating erythema multiforme. Histopathologic and immunohistochemical findings were compatible with a cutaneous pseudolymphoma, variant plasmacytosis cutis.
Conclusions: this is an infrequent disease, of which no cases were reported in Cuba.

REFERENCES

1. Stanić Duktaj S, Novak-Bilić G, Bradamante M, Bukvić I, Lugović-Mihić L. Cutaneous Pseudolymphoma: A Case Report. Acta Dermatovenerol Croat [Internet]. 2019 [citado 02/07/2019];27(2):116-120. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31351507/

2. Smolle J, Torne R, Soyer HP, Kerl H. Immunohistochemical classification of cutaneous pseudolymphomas: delineation of distinct patterns. J Cutan Pathol [Internet]. 1990 [citado 02/07/2019];17(3):149-59. Disponible en: https://pubmed.ncbi.nlm.nih.gov/2197304/. https://doi.org/10.1111/j.1600-0560.1990.tb00074.x

3. Kerl H, Ackerman AB. Inflammatory diseases that simulate lymphomas: cutaneous pseudolymphomas. En: Fitzpatrick TB, Eisen AZ, Wolff K, et al. Dermatology in General Medicine. 4th ed. New York: McGraw-Hill; 1993. p. 1315–1327.

4. Goodlad J, Calonje E. Cutaneous lymphoproliferative diseases and related disorders. En: McKee`s Pathologhy of the Skin. 4th ed. Amsterdam: Elsevier; 2012. p. 1389-1390.

5. Cerroni L, Kerl H. Pseudolymphomas of the skin. En: An illustrated guide to Skin Lymphoma. 2nd ed. Nueva Jersey: Blackwell Publishing Ltd; 2004. p. 157-175.

6. Dautriche CN, Van Driessche F, Chen L, Brinster N, Marmon S. Ulcerative cutaneous plasmacytosis. JAAD Case Rep [Internet]. 2019 [citado 02/07/2019];5(6):540-542. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558310/. https://dx.doi.org/10.1016/j.jdcr.2019.04.004

7. Busam KJ. Dermatopathology. 2nd ed. Pensilvania: Saunders; 2015.

8. Chantachaeng W, Chularojanamontri L. Cutaneous plasmacytosis: a case report and review of pulmonary findings. Dermatol Reports [Internet]. 2011 [citado 02/07/2019];3(3):e39. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211499/. https://dx.doi.org/10.4081/dr.2011.e39

9. Uhara H, Saida T, Ikegawa S, Yamazaki Y, Mikoshiba H, Nijoh S, et al. Primary cutaneous plasmacytosis: report of three cases and review of the literature. Dermatology [Internet]. 1994 [citado 02/07/2019];189(3):251–255. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7949477/. https://doi.org/10.1159/000246848

10. Almazan TH, Jung JY. Cutaneous Plasmacytosis treated with Tocilizumab: A Case Report and Review of the Literature. Madridge J Dermatol Res [Internet]. 2016 [citado 02/07/2019];1(1):1-7. Disponible en: https://madridge.org/journal-of-dermatology-and-research/mjdr-1000101.php. https://doi.org/10.18689/mjdr-1000101